• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Cadence Pharmaceuticals

Related Topics

  1. King Pharmaceuticals
  2. CeCors Incorporated
  3. Ken Lewis
  4. Richard Anderson
  5. Pharmaceutical Product Development
  6. Aubrey McClendon

Popular Topics

  1. Commercial Banks
  2. Emerging Markets
  3. European Union
  4. Interest Rate
  5. Drug Companies

Cadence Pharmaceuticals

Cadence Pharmaceuticals CADX

Last Price$6.70Day Change (%)-4.15%
Open Price$6.99Day Change ($)-0.29
Day Range6.58–7.1552-Week Range2.56–7.53

As of Wed 05/22/2013 06:20 PM EDT | USD

  1. All
  2. Morningstar Articles
  3. Videos
  1. Cadence Pharmaceuticals CADX Q4 2012 Earnings Call Transcript

    Good morning, and welcome to the Cadence Pharmaceuticals Fourth Quarter and Full Year 2012 Financial Results Conference Call. On the call today are Ted Schroeder, President and CEO; Bill LaRue, Senior Vice President and Chief Financial Officer; and Scott Byrd; Senior Vice President and Chief ...

  2. Cadence Pharmaceuticals , Inc. CADX Q4 2011 Earnings Call Transcript

    Good afternoon, and welcome to the Cadence Pharmaceuticals Fourth Quarter and Full Year 2011 Financial Results Conference Call. On the call today are Ted Schroeder, President and CEO; Bill LaRue, Senior Vice President and Chief Financial Officer; Jim Breitmeyer, Executive Vice President and Chief ...

  3. Cadence Pharmaceuticals , Inc. CADX Q4 2010 Earnings Call Transcript

    Good morning. And welcome to the Cadence Pharmaceuticals Fourth Quarter and Full Year 2010 Financial Results Conference Call. On the call today are Ted Schroeder, President and CEO; Bill LaRue, Senior Vice President and Chief Financial Officer; Jim Breitmeyer, Executive Vice President and Chief ...

  4. Our Take on IPO Cumberland's Growth Prospects

    Health-care analyst Brian Laegeler likes the fact that specialty pharma IPO Cumberland is already profitable, but a weak pipeline and a pricey offer price are concerns.

Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.